Business

India

Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc

Business Standard

Aug 25, 2026 · 2:43 PM

0 views

Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc

In 2024, Natco Pharma had invested $8 million in eGenesis, Inc through preferred stock

Continue Reading on Business Standard

This article is aggregated from Business Standard. Click below to read the full story.

Read Full Story

🏷️ Topics: natco pharma invest usbased biotechnology egenesis

🔗 Share this story

Twitter Facebook WhatsApp LinkedIn

Related Stories

Machete Attacks Disrupt Congo Ebola Response (Video)

Machete Attacks Disrupt Congo Ebola Response (Video)

Bloomberg 24m ago

Do you set aside part of your Sunday to get ahead at work? Take our survey.

Do you set aside part of your Sunday to get ahead at work? Take our survey.

Business Insider 35m ago

It’s time for Africa! Zara supplier looks beyond US

It’s time for Africa! Zara supplier looks beyond US

Economic Times 38m ago

(USD) Dollar Debasement Frees EM Currencies From Treasuries’ Weight

(USD) Dollar Debasement Frees EM Currencies From Treasuries’ Weight

Bloomberg 44m ago

Hong Kong’s 2026 Luxury Rents to Rise 5% on Expat Wave, JLL Says

Hong Kong’s 2026 Luxury Rents to Rise 5% on Expat Wave, JLL Says

Bloomberg 47m ago

Get better at work today: The simple meeting habit that can get you noticed at work

Get better at work today: The simple meeting habit that can get you noticed at work

Business Insider 47m ago